
Integrated Therapeutic Innovation: Target Discovery, Evaluation, and Optimization
Innovation driven by computational modeling, drug repurposing, and bioinformatics analyses to identify novel drug targets. It facilitates preclinical and clinical evaluations of potential therapeutics for infectious diseases, type 2 diabetes, cancer, and neurodegenerative diseases. Additionally, it optimizes treatment regimens and dosage strategies to enhance efficacy and minimize the development of resistance.

Collaborative work with CoH LA, USA; AIIMS New Delhi; and TIFR
Enhanced Oncology Care: Advanced Unified Approach
Our study employs advanced mathematical methods to refine oncology treatment approaches, enhancing patient outcomes through tailored strategies.
PUBLICATION:
Interpretability of Machine Intelligence in Medical Image Computing, and Topological Data Analysis and Its Applications for Medical Data.
Springer, book released on Sept.27, 2021.

OptiAAV Technology
OptiAAV utilizes computational simulations to optimize the delivery parameters of AAV gene therapy, OptiAAV identifies personalized treatment strategies tailored to individual patients' disease profiles and genetic backgrounds.
Collaborative work with AIIMS New Delhi
PUBLICATION:
Interpretability of Machine Intelligence in Medical Image Computing, and Topological Data Analysis and Its Applications for Medical Data.
Springer, book released on Sept.27, 2021.